News
The NIH is a leader in medical breakthroughs, with the discovery of new biological molecules, processes and pathways, novel medical technologies, and innovative applications of existing medical knowledge. Many important medical breakthroughs begin in research laboratories at the NIH, and Technology
Neglected diseases affect approximately 1 billion people, primarily in developing countries. However, since most R&D is not focused on neglected diseases, very few new treatments are brought to market. Through its partnerships with international public and private institutions, the NIH Office of
On March 15, 2006, the Meningitis Vaccine Project and the Serum Institute of India announced the successful completion of Phase I clinical trials of a new conjugate vaccine against meningitis A, a bacterium that causes deadly epidemics in sub-Saharan Africa. According to the Meningitis Vaccine
A team headed by Dr. Jeffrey Rubin of the National Cancer Institute has received the 2006 Award for Excellence in Technology Transfer from the Federal Laboratory Consortium for Technology Transfer (FLC). The FLC is a nationwide network of over 700 federal laboratories and centers, organized in 1974